AngioDynamics pushes through pandemic with no layoffs and more research spending
Thursday, April 1, 2021
Source: Albany Business Review
The playbook that Latham medical device maker AngioDynamics and chief executive Jim Clemmer have used to navigate their way through the Covid-19 pandemic isn't the predictable path, but it's working. Here's why.
Click to read the full article.